Defective Angiogenesis Delays Thrombus Resolution

Male Mice, Knockout 0301 basic medicine Time Factors Hypertension, Pulmonary Macrophages Neovascularization, Physiologic Endarterectomy Middle Aged 3. Good health Mice, Inbred C57BL Disease Models, Animal Mice 03 medical and health sciences Gene Expression Regulation Chronic Disease Human Umbilical Vein Endothelial Cells Animals Humans Female Angiogenic Proteins Cells, Cultured Aged
DOI: 10.1161/atvbaha.113.302991 Publication Date: 2014-02-14T02:12:47Z
ABSTRACT
Objective— Restoration of patency is a natural target vascular remodeling after venous thrombosis that involves endothelial cells and smooth muscle cells, as well leukocytes. Acute pulmonary emboli usually resolve <6 months. However, in some instances, thrombi transform into fibrous obstructions, resulting occlusion the deep veins, or chronic thromboembolic hypertension (CTEPH). We proposed dysregulated thrombus angiogenesis may contribute to persistence. Approach Results— Mice with an cell–specific conditional deletion growth factor receptor 2/kinase insert domain protein were used model stagnant flow closely resembling human vein thrombosis. Biochemical functional analyses performed on endarterectomy specimens from patients CTEPH, nonresolving thromboembolism. Endothelial kinase subsequent ablation vascularization delayed resolution. In accordance these findings, organized CTEPH largely devoid structures. Several vessel-specific genes, such receptor, cadherin, podoplanin, expressed at lower levels white than organizing aortic aneurysms. addition, red attenuated angiogenic response induced by factor. Conclusions— present work, we propose mechanism nonresolution demonstrating abates vessel formation, misguiding Medical conditions associated development be compromising early angiogenesis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (101)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....